» Articles » PMID: 15842963

Therapeutic Approaches to Mucus Hypersecretion

Overview
Date 2005 Apr 22
PMID 15842963
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mucolytic and related agents have been in use since prehistoric times. Although widely prescribed and used extensively in over-the-counter preparations, their efficacy and mechanisms of action remain in doubt. These agents belong to several distinct chemical classes. Mucolytic agents such as N-acetyl-cysteine are thiols with a free-sulfhydryl group. They are assumed to break disulfide bonds between gel-forming mucins and thus reduce mucus viscosity. Mucokinetic agents are thiols with a blocked sulfhydryl group. Expectorants such as guaifenesin increase mucus secretion. They may act as irritants to gastric vagal receptors, and recruit efferent parasympathetic reflexes that cause glandular exocytosis of a less viscous mucus mixture. Cough may be provoked. This combination may flush tenacious, congealed mucopurulent material from obstructed small airways and lead to a temporary improvement in dyspnea or the work of breathing. The roles of anticholinergic agents, DNase, and other drugs are also discussed with regard to their roles in reducing mucus production in rhinitis and other airway diseases.

Citing Articles

Rational use of mucoactive medications to treat pediatric airway disease.

Linssen R, Ma J, Bem R, Rubin B Paediatr Respir Rev. 2020; 36:8-14.

PMID: 32653467 PMC: 7297155. DOI: 10.1016/j.prrv.2020.06.007.


The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.

Ohar J, Donohue J, Spangenthal S Chronic Obstr Pulm Dis. 2019; 6(4).

PMID: 31647856 PMC: 7006698. DOI: 10.15326/jcopdf.6.4.2019.0139.


Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection.

Tripathi S, Nikhare A, Sharma G, Shea T, Albrecht H Drug Healthc Patient Saf. 2019; 11:87-94.

PMID: 31632154 PMC: 6791405. DOI: 10.2147/DHPS.S222109.


N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.

Sio T, Blanchard M, Novotny P, Patel S, Rwigema J, Pederson L Mayo Clin Proc. 2019; 94(9):1814-1824.

PMID: 31405750 PMC: 6742495. DOI: 10.1016/j.mayocp.2019.03.031.


Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.

Albrecht H, Dicpinigaitis P, Guenin E Multidiscip Respir Med. 2017; 12:31.

PMID: 29238574 PMC: 5724298. DOI: 10.1186/s40248-017-0113-4.


References
1.
Boman G, Backer U, Larsson S, Melander B, Wahlander L . Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis. 1983; 64(6):405-15. View

2.
Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K . Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J. 1992; 5(2):234-8. View

3.
Saketkhoo K, Januszkiewicz A, SACKNER M . Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest. 1978; 74(4):408-10. DOI: 10.1378/chest.74.4.408. View

4.
Steen S, Ziment I, Freeman D, Thomas J . Evaluation of a new mucolytic drug. Clin Pharmacol Ther. 1974; 16(1):58-62. DOI: 10.1002/cpt1974161part158. View

5.
Chung K, Dent G, McCusker M, Guinot P, Page C, Barnes P . Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet. 1987; 1(8527):248-51. DOI: 10.1016/s0140-6736(87)90066-3. View